This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2018 Jan;15(1):4-5.

doi: 10.1038/nrcardio.2017.204. Epub 2017 Nov 30.

Vascular disease: PCSK9 inhibition in PAD

PMID: 29188814
DOI: 10.1038/nrcardio.2017.204

Comment

Vascular disease: PCSK9 inhibition in PAD

Karina Huynh. Nat Rev Cardiol. 2018 Jan.

. 2018 Jan;15(1):4-5.

doi: 10.1038/nrcardio.2017.204. Epub 2017 Nov 30.

Author

PMID: 29188814
DOI: 10.1038/nrcardio.2017.204

No abstract available

PubMed Disclaimer

Comment on

Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk).
Bonaca MP, Nault P, Giugliano RP, Keech AC, Pineda AL, Kanevsky E, Kuder J, Murphy SA, Jukema JW, Lewis BS, Tokgozoglu L, Somaratne R, Sever PS, Pedersen TR, Sabatine MS. Bonaca MP, et al. Circulation. 2018 Jan 23;137(4):338-350. doi: 10.1161/CIRCULATIONAHA.117.032235. Epub 2017 Nov 13. Circulation. 2018. PMID: 29133605 Clinical Trial.

References

1. Circulation. 2017 Nov 13;:null - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal